Naldemedine Tosylate is a mu-opioid receptor antagonist utilized for the treatment of opioid-induced constipation in adults suffering from chronic non-cancer pain. This category provides essential materials… Read more
Naldemedine Tosylate is a mu-opioid receptor antagonist utilized for the treatment of opioid-induced constipation in adults suffering from chronic non-cancer pain. This category provides essential materials for pharmaceutical research and development, including high-quality reference standards of the active pharmaceutical ingredient, as well as its related degradation products, process impurities, and synthetic intermediates. Laboratories require these compounds to perform rigorous impurity profiling and method validation, ensuring accurate quantification and characterization during drug synthesis. Additionally, stable isotope labelled compounds are available to serve as internal standards for sensitive analytical techniques such as liquid chromatography-tandem mass spectrometry. By incorporating these materials into routine analytical testing and quality control protocols, researchers can verify the purity and stability of Naldemedine Tosylate formulations while maintaining compliance with stringent regulatory requirements throughout the product lifecycle.